LEUKOSCAN 0.31mg powder for injection medication leaflet

V09HA04 sulesomab • Various | Inflammation and infection detection | Technetium (99mtc) compounds

Sulesomab is a radiolabeled monoclonal antibody used in medical imaging for the diagnosis of bone infections and other inflammations. It binds to receptors on the surface of leukocytes, allowing the localization of infection or inflammation sites through scanning.

The medication is administered intravenously, as directed by a doctor, prior to the scan. It is important for patients to be monitored to prevent adverse reactions.

Patients should be aware of potential side effects, such as injection site reactions, fever, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include injection site reactions and fever. In rare cases, severe reactions such as serious allergic reactions may occur. Patients should be informed of these risks before the procedure.

General data about LEUKOSCAN 0.31mg

Substance: sulesomab

Date of last drug list: 01-07-2013

Commercial code: W51532001

Concentration: 0.31mg

Pharmaceutical form: powder for injection

Quantity: 5

Product type: original

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Other substances similar to sulesomab